Mid-Afternoon Market Update: Nasdaq Jumps 400 Points; Sio Gene Therapies Shares Plummet
U.S. stocks extended gains toward the end of trading, with the Nasdaq Composite gaining more than 400 points on Thursday.
Mid-Day Market Update: Teladoc Health Drops Following Q1 Results; Swvl Holdings Shares Jump
U.S. stocks traded higher through trading with the Dow Jones gaining more than 100 points on Thursday.
HC Wainwright & Co. Downgrades Sio Gene Therapies to Sell
HC Wainwright & Co. analyst Joseph Pantginis downgrades Sio Gene Therapies (NASDAQ:SIOX) from Buy to Sell.
The Daily Biotech Pulse: Moderna Seeks FDA Approval For COVID-19 Shot For Children 2-6, Tax Disclosure For Amgen, Fast Track Tags For SQZ Biotech, Timber Pharma Candidates
Here's a roundup of top developments in the biotech space over the last 24 hours:
Stocks That Hit 52-Week Lows On Tuesday
During Tuesday's trading, 505 companies set new 52-week lows.
Recap: Sio Gene Therapies Q3 Earnings
Sio Gene Therapies (NASDAQ:SIOX) reported its Q3 earnings results on Friday, February 11, 2022 at 07:00 AM.
Here's what investors need to know about the announcement.
The Daily Biotech Pulse: Bristol-Myers Squibb Announces $5B Accelerated Buyback, Qiagen Reaps COVID Testing Windfall, WORLDSymposium Presentations Kick In
Here's a roundup of top developments in the biotech space over the last 24 hours:
The Week Ahead In Biotech (Feb. 6-12): Pfizer, AstraZeneca Earnings, Conference Presentations, IPOs And More
Biotech stocks managed to close the week ending Feb. 4 with gains. Stocks recovered along with the broader markets early in the week, but came under pressure midweek amid negative reaction to some big pharma earnings. The sector came back up in the final session for a firm finish.